Unknown

Dataset Information

ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.


ABSTRACT:

SUBMITTER: Chen X 

PROVIDER: S-EPMC7847666 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature